Curve Biosciences

📍 Dallas, United States👥 23 employees💰 Last funded Mar 2023
Biotechnology Research🌐 curvebio.com
Website LinkedIn
Curve uses Whole-Body Intelligence to monitor chronic diseases. We’ve created the first molecular blueprint of the human body by manually curating the world’s largest collection of comprehensively-characterized tissue samples into our Whole-Body Atlas. Trained on the clarity of our atlas, our Whole-Body Intelligence models identify chronic disease states through our Whole-Body Blood tests earlier and more accurately than other methods. Our mission is to provide doctors the best intelligence for their patients and to alleviate the pain of chronic diseases by anchoring medicine in biological truth.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Curve Biosciences?
Curve Biosciences has 2 investors on record on gritt.io.
When did Curve Biosciences last raise funding?
The most recent investment in Curve Biosciences recorded on gritt.io was in March 2023.
What industry is Curve Biosciences in?
Curve Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Curve Biosciences based?
Curve Biosciences is headquartered in Dallas, United States.